The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure-Reference-Cited by-同舟云学术

The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure

Published:2017-10 Issue:17 Volume:70 Page:2128-2136
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Bayes-Genis Antoni,Núñez Julio,Zannad Faiez,Ferreira João Pedro,Anker Stefan D.,Cleland John G.,Dickstein Kenneth,Filippatos Gerasimos,Lang Chim C.,Ng Leong L.,Ponikowski Piotr,Samani Nilesh J.,van Veldhuisen Dirk J.,Zwinderman Aeilko H.,Metra Marco,Lupón Josep,Voors Adriaan A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure;Garg;JAMA,1995

3. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure;Packer;N Engl J Med,1996

4. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011

5. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol;Heart Failure Reviews;2024-06-18

2. Proteome-wide mendelian randomization investigates potential associations in heart failure and its etiology: emphasis on PCSK9;BMC Medical Genomics;2024-02-21

3. Clinical Significance of PCSK9 and Soluble P-selectin in Predicting Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome;Cardiovascular Innovations and Applications;2024

4. Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?;Current Atherosclerosis Reports;2023-12

5. Commentary to “Association between low-density lipoprotein cholesterol level and all-cause mortality in idiopathic dilated cardiomyopathy patients: a single-institutional study”;Acta Cardiologica;2023-10-17